UBS AM’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
Other funds holding DTIL
LCM
UBS AM's DTIL Position: Q3 2026 in Review
UBS AM opened a new position in Precision BioSciences (DTIL) in Q3 2026: 21,610 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3136 among its holdings. This is a return to the name: UBS AM previously reported a position in DTIL as recently as Q1 2022.
UBS AM first reported a position in DTIL in Q2 2020 and has held it in 9 quarters since. The position peaked at $672K in Q2 2021. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.
- UBS AM held 21,610 shares of Precision BioSciences worth $135K as of Q3 2026.
- Precision BioSciences was a new UBS AM position in Q3 2026.
- Precision BioSciences made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3136 holding.
- UBS AM first reported a position in Precision BioSciences in Q2 2020 and has held it in 9 quarters since.
- UBS AM's Precision BioSciences position peaked at $672K in Q2 2021.
- 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.
Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.